Note*: This report requires 5-10 business days to complete.
DelveInsight’s Diabetic Nephropathy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic Nephropathy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic Nephropathy till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic Nephropathy market.
• Identifying patient populations in the global “Diabetic Nephropathymarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Diabetic Nephropathy therapeutics in each of the markets covered.
• To understand the future market competition in the global Diabetic Nephropathy therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Diabetic Nephropathy for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Diabetic Nephropathy overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Diabetic Nephropathy Market
• Global Epidemiology of Diabetic Nephropathy Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Diabetic Nephropathy Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Diabetic Nephropathy (2013-2023)
• Table 7: Diabetic Nephropathy Global Market (USD Millions), (2013-2015)
• Table 8: Diabetic Nephropathy Global Market (USD Millions), (2016-2023)
• Table 9: Diabetic Nephropathy US Market (USD Millions), (2013-2015)
• Table 10: Diabetic Nephropathy US Market (USD Millions), (2016-2023)
• Table 11: Diabetic Nephropathy Germany Market (USD Millions), (2013-2015)
• Table 12: Diabetic Nephropathy Germany Market (USD Millions), (2016-2023)
• Table 13: Diabetic Nephropathy United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Diabetic Nephropathy United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Diabetic Nephropathy France Market (USD Millions), (2013-2015)
• Table 16: Diabetic Nephropathy France Market (USD Millions), (2016-2023)
• Table 17: Diabetic Nephropathy Italy Market (USD Millions), (2013-2015)
• Table 18: Diabetic Nephropathy Italy Market (USD Millions), (2016-2023)
• Table 19: Diabetic Nephropathy Spain Market (USD Millions), (2013-2015)
• Table 20: Diabetic Nephropathy Spain Market (USD Millions), (2016-2023)
• Table 21: Diabetic Nephropathy Japan Market (USD Millions), (2013-2015)
• Table 22: Diabetic Nephropathy Japan Market (USD Millions), (2016-2023)
• Table 23: Diabetic Nephropathy ROW Market (USD Millions), (2013-2015)
• Table 24: Diabetic Nephropathy ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Diabetic Nephropathy Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Diabetic Nephropathy (2013-2023)
• Figure 3: Diabetic Nephropathy Global Market (USD Millions), (2013-2015)
• Figure 4: Diabetic Nephropathy Global Market (USD Millions), (2016-2023)
• Figure 5: Diabetic Nephropathy US Market (USD Millions), (2013-2015)
• Figure 6: Diabetic Nephropathy US Market (USD Millions), (2016-2023)
• Figure 7: Diabetic Nephropathy Germany Market (USD Millions), (2013-2015)
• Figure 8: Diabetic Nephropathy Germany Market (USD Millions), (2016-2023)
• Figure 9: Diabetic Nephropathy United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Diabetic Nephropathy United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Diabetic Nephropathy France Market (USD Millions), (2013-2015)
• Figure 12: Diabetic Nephropathy France Market (USD Millions), (2016-2023)
• Figure 13: Diabetic Nephropathy Italy Market (USD Millions), (2013-2015)
• Figure 14: Diabetic Nephropathy Italy Market (USD Millions), (2016-2023)
• Figure 15: Diabetic Nephropathy Spain Market (USD Millions), (2013-2015)
• Figure 16: Diabetic Nephropathy Spain Market (USD Millions), (2016-2023)
• Figure 17: Diabetic Nephropathy Japan Market (USD Millions), (2013-2015)
• Figure 18: Diabetic Nephropathy Japan Market (USD Millions), (2015-2023)
• Figure 19: Diabetic Nephropathy ROW Market (USD Millions), (2013-2015)
• Figure 20: Diabetic Nephropathy ROW Market (USD Millions), (2016-2023)
• Pfizer Inc.
• Eli Lilly and Company
• Novartis AG
• Mitsubishi Chemical Holdings Corporation
• Bayer AG
• AbbVie Inc.
• NephroGenex Inc.
• Steno Diabetes Center A/S
• Takeda Pharmaceutical Company Limited
• Medpace Holdings Inc.
